Ventum Financial Forecasts Strong Price Appreciation for Calian Group (TSE:CGY) Stock

Calian Group (TSE:CGYGet Free Report) had its price target upped by equities research analysts at Ventum Financial from C$72.00 to C$82.00 in a research note issued on Friday,BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Ventum Financial’s price objective suggests a potential upside of 16.15% from the company’s previous close.

Other research analysts have also recently issued reports about the company. Desjardins upped their price objective on Calian Group from C$59.00 to C$66.00 and gave the stock a “buy” rating in a research report on Thursday, November 27th. Acumen Capital boosted their target price on Calian Group from C$70.00 to C$85.00 and gave the company a “buy” rating in a research note on Friday. Canaccord Genuity Group raised their price target on shares of Calian Group from C$63.00 to C$80.00 in a research note on Friday. Canadian Imperial Bank of Commerce lifted their price objective on shares of Calian Group from C$65.00 to C$76.00 in a report on Friday. Finally, Royal Bank Of Canada increased their target price on shares of Calian Group from C$58.00 to C$60.00 and gave the stock an “outperform” rating in a report on Friday. Six analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Calian Group currently has an average rating of “Buy” and an average price target of C$74.83.

Read Our Latest Report on CGY

Calian Group Stock Up 6.7%

Calian Group stock opened at C$70.60 on Friday. The company has a 50 day moving average of C$60.38 and a 200-day moving average of C$54.13. The company has a quick ratio of 1.20, a current ratio of 1.29 and a debt-to-equity ratio of 39.54. Calian Group has a twelve month low of C$37.70 and a twelve month high of C$71.92. The stock has a market capitalization of C$805.62 million, a PE ratio of 40.11, a price-to-earnings-growth ratio of 2.50 and a beta of 0.70.

Calian Group (TSE:CGYGet Free Report) last posted its quarterly earnings data on Thursday, February 12th. The company reported C$1.03 EPS for the quarter. The business had revenue of C$208.00 million for the quarter. Calian Group had a net margin of 1.50% and a return on equity of 3.37%. On average, equities research analysts anticipate that Calian Group will post 4.9475219 EPS for the current fiscal year.

Calian Group News Summary

Here are the key news stories impacting Calian Group this week:

  • Positive Sentiment: Record Q1 results — Calian reported C$208M revenue (up ~12% YoY) with margin gains and C$1.03 EPS, and management signaled confident growth on the earnings call; this strengthens the growth narrative driving buying interest. Calian Delivers Record Q1 Revenue and Margin Gains
  • Positive Sentiment: Multiple analyst target upgrades — Acumen (to C$85, Buy), Canaccord (to C$80), CIBC (to C$76) and Ventum (to C$82, Buy) raised price targets, signaling broad analyst optimism and providing upward catalyst for the stock. Analyst Ratings Roundup
  • Positive Sentiment: Quarterly dividend declared — Board approved a C$0.28 quarterly dividend (annualized yield ~1.6%), with ex-dividend Feb 25 and record Mar 11; supports shareholder return profile and can attract income-minded buyers.
  • Neutral Sentiment: Corporate governance update — Shareholders re‑elected the board and named Valerie Sorbie as Chair, which preserves leadership continuity but is unlikely to move the stock materially by itself. Shareholder Meeting Results
  • Negative Sentiment: RBC’s moderate target bump to C$60 — Although RBC maintained an “outperform” stance, its target remains well below the current price, indicating at least one major analyst sees less upside and creating potential resistance or caution among some investors. RBC Target Update

About Calian Group

(Get Free Report)

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.

Featured Articles

Analyst Recommendations for Calian Group (TSE:CGY)

Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.